Expanded Access Program (EAP) in Leber's Hereditary Optic Neuropathy (LHON) Patients Treated for 24 Months (Video)
Creator
Thomas Klopstock, Xavier Llòria, Magda Silva, Rudolph Guenther, Felice Lob, Bettina Von Livonius, Claudia Catarino
Subject
Optic Neuropathy
Description
LHON is a mitochondrial genetic disorder resulting in severe bilateral central VA loss. Three primary mitochondrial DNA mutations cause over 90% of cases. Data from idebenone EAP for patients with LHON receiving treatment for at least 24 months were analyzed to assess rate of clinically-relevant recovery (CRR).
Date
2020-03
Language
eng
Format
video/mp4
Source
2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of
NANOS Annual Meeting 2020: Scientific Platform Session III